openPR Logo
Press release

AmpleLogic GMP Document Management System (DMS) for Pharmaceutical Operations

07-07-2026 01:47 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: AmpleLogic

AmpleLogic GMP Document Management System (DMS)

Hyderabad, India - AmpleLogic, a life sciences technology company, has announced its GMP Document Management System (DMS), a platform designed to manage regulated pharmaceutical documents across their entire lifecycle, from initial drafting through final archival.

Paper trails and half digitized records have long created hidden risks in pharmaceutical operations. Slow retrievals, avoidable human error, and chaotic audit preparations are common outcomes when document control is left to spreadsheets, shared drives, or paper binders. AmpleLogic's DMS is built to remove these gaps rather than simply work around them.

For more details visit : https://www.amplelogic.com/products/document-management-system

The platform addresses several recurring pain points for pharma quality teams, including outdated SOPs that slip through weak version control, obsolete printed copies that continue circulating without barcode tracking, and disconnected systems such as LMS, eQMS, LIMS, and MES that break traceability during audits.

Key features of the system include:

- End to end lifecycle control, moving documents through draft, review, approval, release, supersede, and archive stages, each governed by access restrictions and audit trails.
- Word native authoring, allowing documents to be created and edited inside Microsoft Word without files leaving the controlled system.
- Physical to digital reconciliation through role based print permissions, watermarking, and barcode scanning to verify a printed copy's status in real time.
- AI assisted search and OCR, converting scanned documents into searchable text and supporting faster retrieval during audits.
- Integration mapping that links training records to SOP changes and connects change controls to version updates.

For more details check-out : https://www.amplelogic.com/gamp-solutions/document-management-system

On the regulatory side, the platform is positioned as 21 CFR Part 11 ready, with controls aligned to EU Annex 11 and broader GxP expectations, which is particularly relevant for companies operating across multiple regions.

AmpleLogic reports that customers using the system have seen audit findings drop by around 25 percent, document release times improve by roughly 30 percent, and manual processing effort reduced by nearly half. These figures are company reported projections rather than independently verified results.

The DMS is part of AmpleLogic's wider low code platform for life sciences, which currently supports more than 100 pharmaceutical customers worldwide. On G2, the product holds a 4.7 star rating from over 45 reviews, with users often highlighting ease of access and responsive implementation support.

For pharmaceutical companies still relying on manual or partially digitized document processes, AmpleLogic's DMS offers a more traceable and audit ready alternative. Interested teams can request a live demonstration through AmpleLogic's website.

Schedule a free demo today here: https://www.amplelogic.com/schedule-demo?from=%2Fproducts%2Fdocument-management-system

Melange Tower, 2nd Floor, Wing-C, Patrika Nagar, HITEC City, Madhapur - 500081, Hyderabad, India
9:00 AM - 7:00 PM IST
Get in Touch:
Email Us: info@amplelogic.com
Call Us:
1800 2023 269 (Global)
+91-7396660171 (India)

Since 2010, AmpleLogic has been the trusted pharmaceutical software partner for 200,000+ users across 30+ countries - delivering a unified, AI-powered, 21 CFR Part 11 compliant platform that accelerates digital transformation across quality, laboratory, manufacturing, and regulatory operations in pharma, biotech, and life sciences.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AmpleLogic GMP Document Management System (DMS) for Pharmaceutical Operations here

News-ID: 4570641 • Views:

More Releases from AmpleLogic

Is It Finally Time to Replace Your Old LIMS?
Is It Finally Time to Replace Your Old LIMS?
Most QC labs already run some version of a LIMS. That is not really the debate anymore. The real question walking into 2026 is whether the system you installed five or ten years ago is still doing its job or whether it has quietly become one more thing your team must work around. Here is a pattern that shows up in every mature pharma lab: the LIMS handles sample tracking well,
Is It Time to Replace Your Existing LIMS? How AI Is Making Stability Data Smarter
Is It Time to Replace Your Existing LIMS? How AI Is Making Stability Data Smarte …
Laboratory Information Management Systems have been central to pharmaceutical labs for years now. They brought order to sample management, cut down on paperwork, and helped labs move past manual record-keeping. But the way labs operate today looks quite different from how they did even ten years ago. Data volumes have really grown regulatory expectations have become much stricter and teams are under a lot of pressure to make decisions that're faster
AmpleLogic Launches AI-Powered User Access Management Software to Close the Last Compliance Gap in Pharma IT
AmpleLogic Launches AI-Powered User Access Management Software to Close the Last …
For most pharmaceutical and biotech companies, access management has quietly become the weakest link in an otherwise tightly controlled GxP environment. Manufacturing lines are validated. Lab instruments are qualified. Batch records are reviewed line by line. And yet, who actually has access to LIMS, eQMS, or eBMR and whether that access still makes sense often gets tracked in a spreadsheet that nobody updates until an inspector asks for it. AmpleLogic
AmpleLogic Document Management System: Bringing Order and Compliance to Pharma Documentation
AmpleLogic Document Management System: Bringing Order and Compliance to Pharma D …
Paper trails and half-digitized records have long been a quiet liability in pharmaceutical operations which slows down retrievals, inviting human error, and turning every audit into a scramble. AmpleLogic, the Hyderabad-based life sciences technology company, is addressing this directly with its GMP Document Management System (DMS), a platform built to manage the full lifecycle of regulated documents from drafting through obsolescence. For more details Visit : https://www.amplelogic.com/products/document-management-system The system tackles a handful

All 5 Releases


More Releases for DMS

Document Management System (DMS) in Pharma | A Complete Guide
The pharmaceutical industry is one of the most highly regulated sectors in the world. Every process, from drug development to manufacturing, must follow strict rules and maintain proper documentation. This is where a Document Management System (DMS) plays a very important role. A DMS helps pharma companies store, manage, track, and control documents digitally. Instead of using paper-based systems, organisations can use a centralised platform to handle all their documents
HBS Systems Earns Elite Status Kubota DMS Certification
HBS Systems, a leading provider of dealership management solutions for agricultural and heavy equipment dealerships, proudly announces its attainment of Elite Status in the prestigious Kubota Dealership Management System Certification (DMS) for 2024. This significant achievement follows a rigorous two-year certification process spanning 2022 to 2023, during which HBS Systems demonstrated exceptional performance in project participation, timely deliverables, and dealer usage statistics. Certified with an impressive score of 484 points out
Massage Gun Market is Going to Boom : DMS, Hyperice, Pleno
HTF MI introduces new research on Massage Gun covering the micro level of analysis by competitors and key business segments (2023-2029). The Massage Gun explores a comprehensive study of various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing. Some of the major key players profiled
Digital Marketing Software (DMS) Market Set for More Growth
The Digital Marketing Software (DMS) market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029. The report focuses on the Digital Marketing Software (DMS) market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis,
Automotive DMS Market (Driver Monitoring System) Size, Industry Chain, Developme …
Automotive DMS Market research: the installations of DMS soared by 244% on a like-on-like basis in the first nine months of 2021. Our data show that in the first nine months of 2021, China sold 251,511 sets of DMS for new passenger cars, 244% more than in the same period of the previous year, of which 15,201 sets, or 6% of the total were for joint venture brand cars, and 236,310
Newgen launches its DMS OmniDocsTM version 7.0
Newgen Software Technologies Limited, a market leader in Business Process Management (BPM) and Enterprise Content Management (ECM) has announced the launch of its latest version of Document Management System (DMS) solution OmniDocsTM version 7.0. OmniDocs™ provides a highly scalable, unified repository for securely storing and managing enterprise content. OmniDocsTM 7.0 is an ideal solution for Enterprise archival and retrieval of documents in a high-performance environment. It provides an Enterprise Content Management